Poster Session: PK/PD Studies
Christopher M. Rubino, PharmD
Executive Vice President
Institute for Clinical Pharmacodynamics
Schenectady, New York, United States
Shawn Flanagan, PhD
VP, Clinical Pharmacology and Early Development
Cidara Therapeutics
San Diego, California, United States
Jeffrey B. Locke, PhD
Sr. Director Microbiology
Cidara Therapeutics
San Diego, California, United States
Sujata M. Bhavnani, PharmD; MS; FIDSA
Executive Vice President
Institute for Clinical Pharmacodynamics
Schenectady, NY, United States